Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine after spinal anesthesia for cesarean section
ChiCTR1900022019Phase 4Not yet recruiting
- Sponsor
- Central Hospital of Fengxian District, Shanghai
- Start
- Mar 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine, bupivacaine and fentanyl in caesarean delivery (C-section) (3 arms), sponsored by Central Hospital of Fengxian District, Shanghai. Primary endpoints: Maternal blood dexmedetomidine concentration and Fetal umbilical cord blood dexmedetomidine concentration. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
dexmedetomidinebupivacainefentanyl
03
Conditions
caesarean delivery (C-section)
Beyond the preview
Go deeper on ChiCTR1900022019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022019.